Radiation boost may extend life in tough lung cancer

NCT ID NCT05068232

Recruiting now Disease control Sponsor: University of Chicago Source: ClinicalTrials.gov ↗

First seen Mar 17, 2026 · Last updated May 23, 2026 · Updated 9 times

Summary

This study is for people newly diagnosed with extensive-stage small cell lung cancer that has spread. Researchers want to see if adding focused radiation to the standard treatment of durvalumab and chemotherapy can help people live longer without their cancer getting worse. About 49 participants will receive the combination and be followed for up to 48 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University of Chicago Medicine
RECRUITING

Chicago, Illinois, 60637, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
University of Wisconsin Carbone Cancer Center
ACTIVE_NOT_RECRUITING

Madison, Wisconsin, 53792, United States

Conditions

Explore the condition pages connected to this study.

EXTENSIVE-STAGE SMALL CELL LUNG CANCER EXTENSIVE-STAGE SMALL-CELL LUNG CANCER LUNG CANCER SMALL CELL LUNG CANCER